Related Experiment Video
Updated: Jul 20, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Unraveling the complex genetics of familial combined hyperlipidemia
Elina Suviolahti1, Heidi E Lilja, Päivi Pajukanta
1Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA 90095-7088, USA.
Insights
Familial combined hyperlipidemia (FCHL) is a major risk for atherosclerosis. Recent research identified the upstream transcription factor 1 (USF1) gene as a key genetic contributor to FCHL susceptibility.
Area of Science:
- Genetics
- Cardiovascular Disease
- Metabolic Disorders
Background:
- Familial combined hyperlipidemia (FCHL) is a prevalent genetic lipid disorder associated with atherosclerosis and coronary heart disease (CHD).
- FCHL affects 1-6% of Western populations and is characterized by elevated total cholesterol and triglycerides.
- Identifying genetic factors is crucial for understanding FCHL pathogenesis and improving risk assessment.
Purpose of the Study:
- To elucidate the genetic underpinnings of familial combined hyperlipidemia (FCHL).
- To identify specific genes and chromosomal regions associated with FCHL susceptibility.
- To replicate findings from linkage and association studies in independent FCHL cohorts.
Main Methods:
- Review of recent linkage and association studies for FCHL.
- Analysis of candidate gene studies, including lipoprotein lipase (LPL) and APOA1/C3/A4/A5 gene cluster.
- Fine-mapping of chromosomal region 1q21 and identification of the upstream transcription factor 1 (USF1) gene.
Main Results:
- Replication of three chromosomal regions (1q21-23, 11p, 16q22-24.1) associated with FCHL.
- Confirmation of the involvement of LPL and APOA1/C3/A4/A5 gene clusters.
- Identification and replication of the USF1 gene on chromosome 1q21 as a significant contributor to FCHL.
Conclusions:
- The upstream transcription factor 1 (USF1) gene is a key genetic factor underlying familial combined hyperlipidemia.
- Further research is needed to determine the full spectrum of USF1 variants and their precise contribution to FCHL risk.
- Understanding the genetic basis of FCHL is essential for developing targeted prevention and treatment strategies.
Abstract:
Familial combined hyperlipidemia (FCHL) constitutes a substantial risk factor for atherosclerosis since it is observed in about 20% of coronary heart disease (CHD) patients under 60 years. FCHL, characterized by elevated levels of total cholesterol (TC) and triglycerides (TGs), or both, is also one of the most common familial hyperlipidemias with a prevalence of 1%-6% in Western populations. Numerous studies have been performed to identify genes contributing to FCHL. The recent linkage and association studies and their replications are beginning to elucidate the genetic variations underlying the susceptibility to FCHL. Three chromosomal regions on 1q21-23, 11p and 16q22-24.1 have been replicated in different study samples, offering targets for gene hunting. In addition, several candidate gene studies have replicated the influence of the lipoprotein lipase (LPL) gene and apolipoprotein A1/C3/A4/A5 (APOA1/C3/A4/A5) gene cluster in FCHL. Recently, the linked region on chromosome 1q21 was successfully fine-mapped and the upstream transcription factor 1 (USF1) gene identified as the underlying gene for FCHL. This finding has now been replicated in independent FCHL samples. However, the total number of variants, the risk related to each variant and their relative contributions to the disease susceptibility are not known yet.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Catabolism
Polygenic Traits
Polygenic Traits
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
